Prognostic score and cytogenetic risk classification for chronic lymphocytic leukemia patients: Center for International blood and marrow transplant research report
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
In this large cohort of patients with previously treated CLL who underwent RIC HCT, we developed a robust prognostic scoring system of HCT outcomes and a novel cytogenetic-based risk stratification system. These prognostic models can be used for counseling patients, comparing data across studies, and providing a benchmark for future interventions. For future study, we will further validate these models for patients receiving targeted therapies prior to HCT.